Rationale for combination use of targeted agents in ovarian cancer: Do we have one?

Robert L. Coleman; Elise C. Kohn

doi:10.1002/cncr.23604

Rationale for combination use of targeted agents in ovarian cancer: Do we have one?

Robert L. Coleman, Elise C. Kohn

Gynecological Oncology & Reproductive Medicine

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	665-667
Number of pages	3
Journal	Cancer
Volume	113
Issue number	4
DOIs	https://doi.org/10.1002/cncr.23604
State	Published - Aug 15 2008

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.23604

Cite this

@article{ebfe1518618a48d3853d3a71c4f51260,

title = "Rationale for combination use of targeted agents in ovarian cancer: Do we have one?",

author = "Coleman, {Robert L.} and Kohn, {Elise C.}",

year = "2008",

month = aug,

day = "15",

doi = "10.1002/cncr.23604",

language = "English (US)",

volume = "113",

pages = "665--667",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Rationale for combination use of targeted agents in ovarian cancer

T2 - Do we have one?

AU - Coleman, Robert L.

AU - Kohn, Elise C.

PY - 2008/8/15

Y1 - 2008/8/15

UR - http://www.scopus.com/inward/record.url?scp=50249162119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50249162119&partnerID=8YFLogxK

U2 - 10.1002/cncr.23604

DO - 10.1002/cncr.23604

M3 - Comment/debate

C2 - 18623195

AN - SCOPUS:50249162119

SN - 0008-543X

VL - 113

SP - 665

EP - 667

JO - Cancer

JF - Cancer

IS - 4

ER -

Rationale for combination use of targeted agents in ovarian cancer: Do we have one?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this